Ivan Astralaga
Corporate Officer/Principal bij C-RAD AB
Vermogen: 72 618 $ op 30-04-2024
Actieve functies van Ivan Astralaga
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| C-RAD AB | Corporate Officer/Principal | 21-05-2021 | - |
Loopbaan van Ivan Astralaga
Eerdere bekende functies van Ivan Astralaga
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Mevion Medical Systems, Inc.
 Mevion Medical Systems, Inc. Medical SpecialtiesHealth Technology Mevion Medical Systems, Inc. provides proton therapy systems for cancer centers, clinicians and patients worldwide. Its MEVION S250 Series is designed to deliver proton therapy treatments, optimizing both the outcomes and the economics of proton therapy. Its products include Mevion S250i with hyperscan and Mevion 250mx. The company was founded by Kenneth A. Gall in 2004 and is headquartered in Littleton, MA. | Verkoop & Marketing | 01-08-2019 | 01-04-2021 |
Statistieken
Internationaal
| Zweden | 2 |
| Verenigde Staten | 2 |
Operationeel
| Corporate Officer/Principal | 1 |
| Sales & Marketing | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| C-RAD AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Mevion Medical Systems, Inc.
Mevion Medical Systems, Inc. Medical SpecialtiesHealth Technology Mevion Medical Systems, Inc. provides proton therapy systems for cancer centers, clinicians and patients worldwide. Its MEVION S250 Series is designed to deliver proton therapy treatments, optimizing both the outcomes and the economics of proton therapy. Its products include Mevion S250i with hyperscan and Mevion 250mx. The company was founded by Kenneth A. Gall in 2004 and is headquartered in Littleton, MA. | Health Technology |
- Beurs
- Insiders
- Ivan Astralaga
- Ervaring
